Evidence-Based Medicine Guidelines
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Naftopidil for the Treatment of Lower Urinary Tract Symptoms Compatible With Benign Prostatic Hyperplasia." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/454639/all/Naftopidil_for_the_treatment_of_lower_urinary_tract_symptoms_compatible_with_benign_prostatic_hyperplasia.
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/454639/all/Naftopidil_for_the_treatment_of_lower_urinary_tract_symptoms_compatible_with_benign_prostatic_hyperplasia. Accessed March 31, 2023.
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/454639/all/Naftopidil_for_the_treatment_of_lower_urinary_tract_symptoms_compatible_with_benign_prostatic_hyperplasia
Naftopidil for the Treatment of Lower Urinary Tract Symptoms Compatible With Benign Prostatic Hyperplasia [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 March 31]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/454639/all/Naftopidil_for_the_treatment_of_lower_urinary_tract_symptoms_compatible_with_benign_prostatic_hyperplasia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia
ID - 454639
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454639/all/Naftopidil_for_the_treatment_of_lower_urinary_tract_symptoms_compatible_with_benign_prostatic_hyperplasia
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
